Type 2 Diabetes Mellitus: Risk Factors, Management, and the Role of Lifestyle Modification

Authors

  • Nurmatov Og’abek Nasimbek o’g’li Author
  • Zayniddinov Alijon Ahmedovich Author

Keywords:

Type 2 diabetes mellitus, insulin resistance, hyperglycemia, beta-cell dysfunction, obesity, metabolic disorder, glycemic control, lifestyle modification, physical activity, diet, risk factors, prevention, treatment, chronic disease, complications, cardiovascular disease, neuropathy, nephropathy, retinopathy

Abstract

Type 2 diabetes mellitus (T2DM) is a widespread chronic metabolic disorder characterized by insulin resistance and progressive dysfunction of pancreatic beta cells, leading to persistent hyperglycemia. This article aims to analyze the major causes, risk factors, diagnostic criteria, treatment approaches, and preventive strategies associated with T2DM. Special attention is given to modifiable risk factors such as obesity, physical inactivity, and unhealthy dietary patterns. The study is based on a review of scientific literature and clinical data collected from patients, focusing on the relationship between lifestyle habits and glycemic control. The results demonstrate that patients who adhere to balanced nutrition, regular physical activity, and prescribed medication achieve significantly better outcomes. The article also discusses the long-term complications of uncontrolled diabetes, including cardiovascular diseases, neuropathy, nephropathy, and retinopathy. The findings emphasize the critical importance of early diagnosis, patient education, and comprehensive management strategies in reducing disease burden and improving quality of life

References

1. American Diabetes Association. (2024). Standards of Medical Care in

Diabetes—2024. Diabetes Care, 47(Supplement 1), S1–S350.

2. World Health Organization. (2023). Diabetes. Retrieved from:

https://www.who.int/news-room/fact-sheets/detail/diabetes

3. International Diabetes Federation. (2021). IDF Diabetes Atlas (10th ed.).

Brussels, Belgium.

4. DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H.,

Holst, J. J., & Simonson, D. C. (2015). Type 2 diabetes mellitus. Nature

Reviews Disease Primers, 1, 15019.

5. UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive bloodglucose control with sulphonylureas or insulin compared with conventional

treatment. The Lancet, 352(9131), 837–853.

6. Hu, F. B. (2011). Globalization of diabetes: The role of diet, lifestyle, and

genes. Diabetes Care, 34(6), 1249–1257.

7. Knowler, W. C., Barrett-Connor, E., Fowler, S. E., et al. (2002). Reduction

in the incidence of type 2 diabetes with lifestyle intervention. The New

England Journal of Medicine, 346(6), 393–403.

8. Zheng, Y., Ley, S. H., & Hu, F. B. (2018). Global aetiology and

epidemiology of type 2 diabetes mellitus. Nature Reviews Endocrinology,

14(2), 88–98.

9. Cho, N. H., Shaw, J. E., Karuranga, S., et al. (2018). IDF Diabetes Atlas:

Global estimates of diabetes prevalence. Diabetes Research and Clinical

Practice, 138, 271–281.

10.Davies, M. J., D’Alessio, D. A., Fradkin, J., et al. (2018). Management of

hyperglycemia in type 2 diabetes. Diabetes Care, 41(12), 2669–2701.

Published

2026-05-05